Uncovering cancer’s invisibility cloak

Issue: BCMJ, vol. 58 , No. 9 , November 2016 , Pages 524-525 News

UBC researchers have discovered how cancer cells become invisible to the body’s immune system, a crucial step that allows tumors to metastasize and spread. As cancer cells evolve over time they may lose the ability to create a protein known as interleukein-33 (IL-33). When IL-33 disappears in the tumor, the body’s immune system has no way of recognizing the cancer cells and they can begin to metastasize.

Researchers found that the loss of IL-33 occurs in epithelial carcinomas, including prostate, kidney, breast, lung, uterine, cervical, pancreatic, skin, and many others.

Professor Wilfred Jefferies is a senior author of the study, working in the Michael Smith Laboratories and as a professor in the Departments of Medical Genetics and Microbiology and Immunology at UBC. Working with researchers at the Vancouver Prostate Centre to study several hundred patients, study authors found that patients with prostate or renal cancers whose tumors have lost IL-33 had more rapid recurrence of their cancer over a 5-year period. They will now begin studying whether testing for IL-33 is an effective way to monitor the progression of certain cancers.

The study, “Discovery of a metastatic immune escape mechanism initiated by the loss of expression of the tumour biomarker interleukin-33,” was published in the journal Scientific Reports.

. Uncovering cancer’s invisibility cloak. BCMJ, Vol. 58, No. 9, November, 2016, Page(s) 524-525 - News.



Above is the information needed to cite this article in your paper or presentation. The International Committee of Medical Journal Editors (ICMJE) recommends the following citation style, which is the now nearly universally accepted citation style for scientific papers:
Halpern SD, Ubel PA, Caplan AL, Marion DW, Palmer AM, Schiding JK, et al. Solid-organ transplantation in HIV-infected patients. N Engl J Med. 2002;347:284-7.

About the ICMJE and citation styles

The ICMJE is small group of editors of general medical journals who first met informally in Vancouver, British Columbia, in 1978 to establish guidelines for the format of manuscripts submitted to their journals. The group became known as the Vancouver Group. Its requirements for manuscripts, including formats for bibliographic references developed by the U.S. National Library of Medicine (NLM), were first published in 1979. The Vancouver Group expanded and evolved into the International Committee of Medical Journal Editors (ICMJE), which meets annually. The ICMJE created the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals to help authors and editors create and distribute accurate, clear, easily accessible reports of biomedical studies.

An alternate version of ICMJE style is to additionally list the month an issue number, but since most journals use continuous pagination, the shorter form provides sufficient information to locate the reference. The NLM now lists all authors.

BCMJ standard citation style is a slight modification of the ICMJE/NLM style, as follows:

  • Only the first three authors are listed, followed by "et al."
  • There is no period after the journal name.
  • Page numbers are not abbreviated.


For more information on the ICMJE Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, visit www.icmje.org

BCMJ Guidelines for Authors

Leave a Reply